Steven Cohen Voyager Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $37,344 - $67,094	6,224 New	6,224 $47,000
Q3 2022 Nov 14, 2022	BUY	$5.57 - $7.47 $1.61 Million - $2.16 Million	289,420 New	289,420 $1.71 Million
Q4 2018 Feb 14, 2019	SELL	$8.59 - $18.05 $875,965 - $1.84 Million	-101,975 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.11 - $21.74 $1.74 Million - $2.22 Million	101,975 New	101,975 $1.93 Million
Q4 2017 Feb 14, 2018	SELL	$12.26 - $25.88 $1.6 Million - $3.39 Million	-130,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $1.1 Million - $2.7 Million	130,900	130,900 $2.7 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.